Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)
Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%
Phibro Animal Health cash
Cash and short-term investments held at the end of each period.
Phibro Animal Health's cash was $81.99M at Jun 30, 2026. For fiscal 2026 it was $81.99M, up 6.4% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $114.61M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $81.99M | +6.4% |
| FY2025 | Jun 30, 2025 | $77.04M | -32.8% |
| FY2024 | Jun 30, 2024 | $114.61M | +41.0% |
| FY2023 | Jun 30, 2023 | $81.28M | -10.9% |
| FY2022 | Jun 30, 2022 | $91.25M | -0.4% |
| FY2021 | Jun 30, 2021 | $91.60M | +0.3% |
| FY2020 | Jun 30, 2020 | $91.34M | +12.0% |
| FY2019 | Jun 30, 2019 | $81.57M | +3.0% |
| FY2018 | Jun 30, 2018 | $79.17M | +41.2% |
| FY2017 | Jun 30, 2017 | $56.08M | +66.9% |
| FY2016 | Jun 30, 2016 | $33.61M | +15.0% |
| FY2015 | Jun 30, 2015 | $29.22M | +147.2% |
| FY2014 | Jun 30, 2014 | $11.82M | -56.8% |
| FY2013 | Jun 30, 2013 | $27.37M | -49.2% |
| FY2012 | Jun 30, 2012 | $53.90M | +10.9% |
| FY2011 | Jun 30, 2011 | $48.60M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $81.99M | +6.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $77.45M | +10.1% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $74.51M | +11.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $85.27M | -5.1% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $77.04M | -32.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $70.35M | -28.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $67.07M | -27.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $89.84M | -1.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $114.61M | +41.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $98.75M | +27.8% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $92.49M | +17.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $91.15M | +5.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $81.28M | -10.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $77.24M | -16.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $78.42M | -17.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $86.28M | -11.2% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $91.25M | -0.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $92.85M | -0.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $95.49M | -0.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $97.18M | +5.7% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $91.60M | +0.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $93.10M | +13.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $95.53M | +27.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $91.97M | +16.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $91.34M | +12.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $81.75M | -3.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $75.18M | -6.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $78.89M | +4.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $81.57M | +3.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $84.88M | +12.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $80.34M | +19.6% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $75.86M | +22.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $79.17M | +41.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $75.55M | +53.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $67.19M | +71.3% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $62.10M | +66.0% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $56.08M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $49.31M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $39.22M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $37.42M | – |
See a number that looks wrong?